Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

Clinical trial NCT03226704 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT03226704
Sponsor: National Cancer Institute (NCI)
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Leukemia Lymphoma Acute Lymphoblastic Leukemia Diffuse Large B Cell Lymphoma Non-Hodgkin's Lymphoma

Start date: 2017-08-14
Primary completion: 2030-01-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.